A detailed history of Invst, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Invst, LLC holds 4,680 shares of BMY stock, worth $189,306. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,680
Previous 4,645 0.75%
Holding current value
$189,306
Previous $238,000 6.3%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 24, 2024

BUY
$47.98 - $54.4 $1,679 - $1,904
35 Added 0.75%
4,680 $253,000
Q4 2023

Feb 07, 2024

SELL
$48.48 - $57.85 $18,567 - $22,156
-383 Reduced 7.62%
4,645 $238,000
Q3 2023

Nov 21, 2023

BUY
$57.89 - $64.73 $10,941 - $12,233
189 Added 3.91%
5,028 $291,000
Q2 2023

Jul 28, 2023

BUY
$63.71 - $70.74 $18,412 - $20,443
289 Added 6.35%
4,839 $309,000
Q1 2023

Apr 28, 2023

BUY
$65.71 - $74.53 $7,753 - $8,794
118 Added 2.66%
4,550 $315,000
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $753 - $891
-11 Reduced 0.25%
4,432 $318,000
Q3 2022

Nov 23, 2022

SELL
$0.13 - $76.84 $20 - $11,910
-155 Reduced 3.37%
4,443 $304,000
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $1,670 - $1,839
-23 Reduced 0.5%
4,598 $344,000
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $33,260 - $39,882
541 Added 13.26%
4,621 $352,000
Q4 2021

Feb 25, 2022

SELL
$53.63 - $62.52 $527,343 - $614,759
-9,833 Reduced 70.67%
4,080 $277,000
Q3 2021

Nov 10, 2021

SELL
$59.17 - $69.31 $4,023 - $4,713
-68 Reduced 0.49%
13,913 $823,000
Q2 2021

Jul 19, 2021

BUY
$61.91 - $67.42 $2,662 - $2,899
43 Added 0.31%
13,981 $941,000
Q1 2021

Jun 23, 2021

SELL
$59.34 - $66.74 $712 - $800
-12 Reduced 0.09%
13,938 $870,000
Q4 2020

Jun 23, 2021

SELL
$57.74 - $65.43 $692 - $785
-12 Reduced 0.09%
13,950 $865,000
Q3 2020

Jun 23, 2021

BUY
$57.43 - $63.64 $582,971 - $646,009
10,151 Added 266.36%
13,962 $835,000
Q2 2020

Jun 23, 2021

BUY
$54.82 - $64.09 $208,919 - $244,246
3,811 New
3,811 $226,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Invst, LLC Portfolio

Follow Invst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.